PrescriptionDrugs.org

Atorvastatin

Key Takeaway

Atorvastatin (brand name Lipitor) is a statin medication that lowers LDL cholesterol by blocking an enzyme in the liver that produces cholesterol. It is one of the most prescribed medications worldwide and significantly reduces the risk of heart attack and stroke. Most people tolerate it well, though muscle-related side effects should be monitored.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

How does Atorvastatin work?

Atorvastatin belongs to the statin class (HMG-CoA reductase inhibitors), which are the most widely prescribed medications for lowering cholesterol and preventing cardiovascular disease [1, 2]. Statins have decades of clinical evidence demonstrating their ability to reduce heart attacks, strokes, and cardiovascular death [3].

Cholesterol is produced primarily in the liver through a complex biochemical pathway. Atorvastatin works by blocking HMG-CoA reductase, the enzyme responsible for an early and rate-limiting step in cholesterol synthesis [1]. When the liver produces less cholesterol, it responds by pulling LDL cholesterol ("bad cholesterol") out of the bloodstream by upregulating LDL receptors on hepatocyte surfaces, reducing circulating LDL levels [1, 12].

Atorvastatin is classified as a high-intensity statin, meaning it can lower LDL cholesterol by 50% or more at its higher doses (40-80 mg) [1, 2]. It also modestly raises HDL cholesterol ("good cholesterol") and lowers triglycerides [1]. Beyond its cholesterol-lowering effects, atorvastatin has pleiotropic effects including stabilizing arterial plaques, reducing inflammation in blood vessel walls, and improving endothelial function [3].

Atorvastatin is the most-prescribed statin globally and was the best-selling pharmaceutical product in history when sold under the brand name Lipitor, generating over $125 billion in lifetime sales before going generic in 2011. The TNT trial demonstrated that high-dose atorvastatin (80 mg) significantly reduced cardiovascular events compared to low-dose (10 mg) in patients with stable coronary disease [4], while the CARDS trial showed benefit in patients with type 2 diabetes [5], and ASCOT-LLA demonstrated primary prevention efficacy in hypertensive patients [6].

What to expect when starting Atorvastatin

After starting atorvastatin, you may not feel any immediate effects because high cholesterol itself does not cause symptoms [1]. Blood lipid improvements are measurable within 2 weeks, with maximum LDL reduction typically seen at 4-6 weeks [1]. Your doctor will usually check a fasting lipid panel 4-12 weeks after starting or adjusting the dose [2].

Most people tolerate atorvastatin very well [1]. Muscle-related symptoms (myalgia) are the most discussed side effect and occur in approximately 5-10% of patients in clinical practice, though rates in blinded clinical trials are much lower (1-2% above placebo), suggesting a significant nocebo effect [9, 10]. The SAMSON trial used an innovative n-of-1 design and found that 90% of statin side effects were also experienced during placebo periods [10]. If you develop unexplained muscle pain, tenderness, or weakness, notify your doctor [1, 11].

You can take atorvastatin at any time of day, with or without food, because its long half-life maintains consistent cholesterol-lowering activity regardless of timing [1]. This is an advantage over some other statins (like simvastatin) that are preferably taken in the evening.

Liver enzyme elevations (transaminases) occur in about 0.7% of patients [1]. Routine liver monitoring is no longer recommended by current ACC/AHA guidelines unless symptoms develop, but your doctor may check baseline values [2]. Statins may slightly increase the risk of developing type 2 diabetes, though the cardiovascular benefits far outweigh this risk for most patients [8, 11].

What are the common side effects of Atorvastatin?

Common

Common(12 effects)
  • Nasopharyngitis (cold symptoms)8.3%
  • Arthralgia (joint pain)6.9%
  • Diarrhea6.8%
  • Pain in extremity6.0%
  • Urinary tract infection5.7%
  • Dyspepsia (indigestion)4.7%
  • Nausea4.0%
  • Musculoskeletal pain3.8%
  • Muscle spasms3.6%
  • Myalgia (muscle pain)3.5%
  • Insomnia3.0%
  • Headache2.5%

What are the serious side effects of Atorvastatin?

Serious

Serious(5 effects)
  • Myopathy (CK >10x upper limit of normal)Rare (0.1-0.2%)
  • Hepatotoxicity (ALT/AST >3x ULN)0.7% (dose-related, more common at 80 mg)
  • New-onset type 2 diabetesApproximately 1 additional case per 250 patients treated for 4 years
  • Immune-mediated necrotizing myopathy (IMNM)Very rare (estimated 2-3 per 100,000 statin users)
  • Hemorrhagic strokeVery rare; observed in SPARCL trial (2.3% vs 1.4% placebo in patients with prior stroke)
Life-Threatening(1 effect)
  • RhabdomyolysisVery rare (<0.1%); risk increases with high doses, interacting drugs, and renal impairment

What drugs interact with Atorvastatin?

  • Contraindicated
    Cyclosporine (Sandimmune, Neoral) Cyclosporine dramatically increases atorvastatin exposure via CYP3A4 and OATP1B1 inhibition. Concurrent use is contraindicated due to severe rhabdomyolysis risk.
  • Major
    Clarithromycin (Biaxin) Clarithromycin is a strong CYP3A4 inhibitor that significantly increases atorvastatin levels, raising the risk of rhabdomyolysis. Use azithromycin as an alternative.
  • Major
    Gemfibrozil (Lopid) Gemfibrozil increases statin exposure and significantly raises the risk of myopathy and rhabdomyolysis. Fenofibrate is a safer fibrate alternative.
  • Moderate
    Warfarin (Coumadin) Atorvastatin may modestly increase warfarin effect and prolong INR. Monitor INR closely when initiating or adjusting atorvastatin dose.
  • Moderate
    Digoxin (Lanoxin) Atorvastatin may increase digoxin levels by approximately 20%. Monitor digoxin concentrations and watch for signs of toxicity.
  • Moderate
    Amlodipine (Norvasc) Amlodipine is a mild CYP3A4 inhibitor that increases atorvastatin exposure by about 18%. Limit atorvastatin to 80 mg daily when combined.
  • Moderate
    Grapefruit juice Grapefruit juice inhibits intestinal CYP3A4, increasing atorvastatin bioavailability. Avoid consuming large quantities of grapefruit while taking atorvastatin.
  • Moderate
    Colchicine (Colcrys) Concurrent use of atorvastatin and colchicine may increase the risk of myopathy. Use with caution and monitor for muscle pain or weakness.

View all drug interactions →

Can I eat certain foods or drink alcohol with Atorvastatin?

Atorvastatin can be taken with or without food; absorption is not significantly affected by meals [1]. Unlike some other statins, it can be taken at any time of day due to its long half-life [1].

Grapefruit: Large quantities of grapefruit juice (more than 1.2 liters per day) can increase atorvastatin blood levels by inhibiting CYP3A4 in the intestinal wall [1, 12]. Occasional small amounts of grapefruit are generally acceptable, but patients should avoid consuming large amounts regularly. The FDA has issued guidance on statin-specific drug interactions [11].

Alcohol: Moderate alcohol consumption is generally acceptable with atorvastatin [1]. However, heavy alcohol use increases the risk of liver damage. Patients with active liver disease or unexplained persistent transaminase elevations should not take atorvastatin [1, 2].

What is the typical dosage for Atorvastatin?

Atorvastatin is dosed once daily and can be taken at any time of day, with or without food [1].

Adult Dosing [1, 2]: - Starting dose: 10-20 mg once daily (most patients) - High-risk patients (e.g., familial hypercholesterolemia, established CVD): May start at 40 mg - Dose range: 10-80 mg once daily - Maximum dose: 80 mg/day

Dose by Intensity [2]: - Moderate intensity (lowers LDL 30-49%): 10-20 mg - High intensity (lowers LDL >=50%): 40-80 mg

Pediatric Dosing (ages 10-17) [1]: - Heterozygous familial hypercholesterolemia: 10-20 mg/day

Special Populations [1]: - No dose adjustment needed for renal impairment - Contraindicated in active liver disease

Monitoring [1, 2]: - Fasting lipid panel at baseline, 4-12 weeks after starting, then every 3-12 months - Baseline liver function tests (ALT); repeat only if symptoms develop [2] - CK only if muscle symptoms develop - Fasting glucose/HbA1c at baseline and periodically (to monitor for new-onset diabetes) [8]

Tablets may be swallowed whole. If a dose is missed, take it as soon as remembered unless close to next dose [1].

How much does Atorvastatin cost?

Atorvastatin went generic in November 2011, making it dramatically more affordable than the original Lipitor brand [1].

Generic pricing: Generic atorvastatin costs approximately $4-$15 per month for a 30-day supply. It is available on many $4 generic drug lists at major pharmacy chains [12]. The cost is similar across all strengths (10, 20, 40, 80 mg).

Brand Lipitor: Brand-name Lipitor is rarely prescribed now and costs approximately $350-$500 per month without insurance. There is no clinical advantage to the brand [1].

Insurance coverage: Atorvastatin is a Tier 1 preferred generic on virtually all formularies, including Medicare Part D [2]. Copays are typically $0-$10.

Discount programs: GoodRx and similar services can reduce the price to $3-$8/month [12]. Mark Cuban Cost Plus Drugs offers atorvastatin at reduced prices.

Combination products: Atorvastatin is available in combination with amlodipine (Caduet generic) for patients who take both medications [1].

Is Atorvastatin safe during pregnancy or breastfeeding?

Pregnancy: Atorvastatin is CONTRAINDICATED in pregnancy (former FDA Category X) [1, 11]. Cholesterol and its biosynthesis products are essential for fetal development, including synthesis of steroid hormones and cell membranes [1]. Statins should be discontinued as soon as pregnancy is recognized. Women of childbearing potential should use effective contraception [1, 2].

Breastfeeding: It is not known whether atorvastatin is excreted in human breast milk [1]. Due to the potential for serious adverse reactions in nursing infants from disruption of lipid metabolism, atorvastatin should NOT be used during breastfeeding [1].

Is there a generic version of Atorvastatin?

Since Lipitor went generic in November 2011, there is essentially no reason to use brand-name Lipitor [1]. All generic atorvastatin products are rated AB-equivalent by the FDA.

- Generic atorvastatin: $4-$15/month. Available from numerous manufacturers. Bioequivalent to Lipitor [12]. - Brand Lipitor: $350-$500/month. Same active ingredient, same efficacy. No clinical advantage [1].

The savings from using generic over brand is typically $4,000-$6,000 per year.

Combination product: Generic amlodipine/atorvastatin (Caduet generic) is available for patients taking both drugs [1]. The 2018 ACC/AHA cholesterol guidelines recommend high-intensity statin therapy (atorvastatin 40-80 mg) for patients with established atherosclerotic cardiovascular disease [2].

For Caregivers

If you are a caregiver for someone taking atorvastatin, here are key points:

Medication adherence: Because high cholesterol does not cause symptoms, patients may not feel motivated to take their statin daily [2]. Emphasize that the benefit is in preventing future heart attacks and strokes — the CTT meta-analysis showed a 22% reduction in major vascular events per 1 mmol/L LDL-C reduction [3].

Muscle symptoms: Ask periodically about new or unusual muscle pain, tenderness, or weakness [1]. Severe cases (rhabdomyolysis) are a medical emergency requiring dark-colored urine and severe weakness to be reported immediately [1]. However, reassure that the SAMSON trial showed most statin side effects are nocebo-related [10].

Diabetes risk: Long-term statin use slightly increases the risk of developing type 2 diabetes, but cardiovascular benefits generally outweigh this risk [8, 11].

Drug interactions: Always inform all healthcare providers about statin use [1]. Avoid large quantities of grapefruit juice [1, 12].

Do not stop abruptly: Stopping a statin without medical guidance can allow cholesterol to rebound and may increase cardiovascular risk [2].

Frequently asked questions about Atorvastatin

References

  1. [Regulatory] FDA prescribing information for Atorvastatin Calcium Tablets (Lipitor). https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020702s081lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Grundy SM et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://pubmed.ncbi.nlm.nih.gov/30423393/ Accessed 2025-01-15.
  3. [Clinical] Cholesterol Treatment Trialists Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet. 2010;376:1670-1681. https://pubmed.ncbi.nlm.nih.gov/21067804/ Accessed 2025-01-15.
  4. [Clinical] LaRosa JC et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease (TNT). N Engl J Med. 2005;352:1425-1435. https://pubmed.ncbi.nlm.nih.gov/15755765/ Accessed 2025-01-15.
  5. [Clinical] Colhoun HM et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes (CARDS). Lancet. 2004;364:685-696. https://pubmed.ncbi.nlm.nih.gov/15325833/ Accessed 2025-01-15.
  6. [Clinical] Sever PS et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients (ASCOT-LLA). Lancet. 2003;361:1149-1158. https://pubmed.ncbi.nlm.nih.gov/12686036/ Accessed 2025-01-15.
  7. [Clinical] Amarenco P et al. High-dose atorvastatin after stroke or transient ischemic attack (SPARCL). N Engl J Med. 2006;355:549-559. https://pubmed.ncbi.nlm.nih.gov/16899775/ Accessed 2025-01-15.
  8. [Clinical] Sattar N et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375:735-742. https://pubmed.ncbi.nlm.nih.gov/20167359/ Accessed 2025-01-15.
  9. [Clinical] Gupta A et al. Adverse events associated with unblinded but not with blinded statin therapy in the ASCOT-LLA trial. Lancet. 2017;389:2473-2481. https://pubmed.ncbi.nlm.nih.gov/28476288/ Accessed 2025-01-15.
  10. [Clinical] Howard JP et al. Side effect patterns in a crossover trial of statin, placebo, and no treatment (SAMSON). J Am Coll Cardiol. 2021;78:1210-1222. https://pubmed.ncbi.nlm.nih.gov/34531021/ Accessed 2025-01-15.
  11. [Regulatory] FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs (2012). https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs Accessed 2025-01-15.
  12. [Observational] DrugBank entry for Atorvastatin (DB01076). https://go.drugbank.com/drugs/DB01076 Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: